Nurofen manufacturer has been fined for misleading consumers. The federal court found that the manufacturer has its range of specific pain products, which are marketed as supposedly aiming at different types of pain despite the fact that they contain the same ingredients.
Nurofen manufacturer Reckitt Benckiser has been fined $1.7 million for breaching consumer law. Judge James Edelman of Federal Court in Sydney ordered the fine on Friday.
Australian Competition and Consumer Commission (ACCC) had asked the federal court to Fine Reckitt 6 million as penalty. It said that there needed to be “some serious taking away of product” for misleading consumer over a medicine, reported The Guardian.
The court found Reckitt Benckiser’s painkiller range has the same ingredient ibuprofen lysine 342mg. The products promise to give relief in back pain, period pain, tension headache or migraine but the court has reason to believe that it is not possible to give relief for pain in such manner.
The lawyer for Reckitt Benckiser, however, argued that rational consumers would not think that a pain specific medicine is any more effective than a regular one, ABC stated.
Nurofen in its statement said that it accepts the verdict by the federal court, but at the same time maintained that it did not intentionally mislead people.
The statement said that the pain relief range was “introduced with the intention to provide easy navigation of pain relief options, particularly within the grocery environment where pharmacy support is not available.”
It further stated, “Nurofen did not intend to mislead consumers, however, we recognise that we could have done more to assist our consumers in navigating the Nurofen Specific Pain Range.”
The company also said that it should have clearly mentioned that all products of the pain relief range were equally effective. In other words, it should have stated that none were more effective on a particular pain than any other.
In December 2015, the company was given three months to withdraw the sale of the product range. It also agreed to place some stickers on the products to rectify the mistake. However, ACCC claimed that the stickers were being obscured in some supermarkets.
Nurofen lied about specific pain relief, Colgate and Woolworths colluded to increase prices, yet no ICAC into business? #auspol Come on Libs
— darc (@darcstei) April 29, 2016
— Shydoll (@Shydoll9) April 29, 2016
Recently, a law was passed by the Senate for protecting consumers against excessive surcharges in Australia. The new law gives the power to the ACCC to crack down on offending merchants.